Geradts J - Search Results

1

Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Zöchbauer-Müller S, et al. Among authors: geradts j. Cancer Res. 2001 Jan 1;61(1):249-55. Cancer Res. 2001. PMID: 11196170

2

Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.

Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD. Geradts J, et al. Clin Cancer Res. 1999 Apr;5(4):791-800. Clin Cancer Res. 1999. PMID: 10213214 Clinical Trial.

3

Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features.

Geradts J, Fong KM, Zimmerman PV, Minna JD. Geradts J, et al. Br J Cancer. 2000 Mar;82(6):1191-7. doi: 10.1054/bjoc.1999.1062. Br J Cancer. 2000. PMID: 10735505 Free PMC article.

4

Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.

Wistuba II, Tomlinson GE, Behrens C, Virmani A, Geradts J, Blum JL, Minna JD, Gazdar AF. Wistuba II, et al. Among authors: geradts j. Genes Chromosomes Cancer. 2000 Aug;28(4):359-69. doi: 10.1002/1098-2264(200008)28:4<359::aid-gcc1>3.0.co;2-n. Genes Chromosomes Cancer. 2000. PMID: 10862044

5

5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.

Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD. Zöchbauer-Müller S, et al. Among authors: geradts j. Cancer Res. 2001 May 1;61(9):3581-5. Cancer Res. 2001. PMID: 11325823

6

Human lung cancer cell lines exhibit resistance to retinoic acid treatment.

Geradts J, Chen JY, Russell EK, Yankaskas JR, Nieves L, Minna JD. Geradts J, et al. Cell Growth Differ. 1993 Oct;4(10):799-809. Cell Growth Differ. 1993. PMID: 8274449

7

Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation.

Zöchbauer-Müller S, Fong KM, Geradts J, Xu X, Seidl S, End-Pfützenreuter A, Lang G, Heller G, Zielinski CC, Gazdar AF, Minna JD. Zöchbauer-Müller S, et al. Among authors: geradts j. Oncogene. 2005 Sep 15;24(41):6249-55. doi: 10.1038/sj.onc.1208775. Oncogene. 2005. PMID: 15940253

8

Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.

Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM, Kandioler D, Berger W, Stiglbauer W, Depisch D, Pirker R, Zielinski CC, Zöchbauer-Müller S. Heller G, et al. Among authors: geradts j. Breast Cancer Res Treat. 2007 Jul;103(3):283-91. doi: 10.1007/s10549-006-9377-7. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260099

9

Rb and p16INK4a expression in resected non-small cell lung tumors.

Kratzke RA, Greatens TM, Rubins JB, Maddaus MA, Niewoehner DE, Niehans GA, Geradts J. Kratzke RA, et al. Among authors: geradts j. Cancer Res. 1996 Aug 1;56(15):3415-20. Cancer Res. 1996. PMID: 8758904

10

Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.

Geradts J, Maynard R, Birrer MJ, Hendricks D, Abbondanzo SL, Fong KM, Barrett JC, Lombardi DP. Geradts J, et al. Am J Pathol. 1999 Jun;154(6):1665-71. doi: 10.1016/S0002-9440(10)65422-3. Am J Pathol. 1999. PMID: 10362791 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page